目次
Chapter- 1: Introduction
Study Background
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Table Summary : Global Market for Osteoarthritis Therapeutics, by Anatomy, Through 2026
Figure Summary : Global Market Shares of Osteoarthritis Therapeutics, by Anatomy, 2020
Chapter- 3: Market and Technology Background
Osteoarthritis
Chapter- 4: Impact of COVID-19
Overview
Osteoarthritis and COVID-19
OA Drugs and Viral Infections
Conclusion
Direct Impact of COVID-19 on Revenue of Companies
Chapter- 5: Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Competitive Landscape
Chapter- 6: Market Breakdown by Anatomy
Global Market for Osteoarthritis Therapeutics by Anatomy
Chapter- 7: Market Breakdown by Drug Type
Global Market for Osteoarthritis Therapeutics by Drug Type
Chapter- 8: Market Breakdown by Route of Administration
Global Market for Osteoarthritis Therapeutics by Route of Administration
Chapter- 9: Market Breakdown by Drug Classification (OTC/Prescription)
Global Market for Osteoarthritis Therapeutics by Drug Classification
Chapter- 10: Market Breakdown by Region
Global Market for Osteoarthritis Therapeutics Market by Region
Chapter- 11: Company Profiles
ABBOTT LABORATORIES
ANIKA THERAPEUTICS INC.
BAYER AG
BIOVENTUS
ELI LILLY AND CO.
FERRING B.V.
FIDIA FARMACEUTICI S.P.A.
FLEXION THERAPEUTICS INC.
GLAXOSMITHKLINE PLC
HORIZON THERAPEUTICS PLC
JOHNSON & JOHNSON INC.
NOVARTIS AG
PFIZER INC.
SANOFI
SEIKAGAKU CORP.
Chapter- 12: Appendix: List of Acronyms
Table 59 : Acronyms Used in This Report
